BD Insyte™ Autoguard™ Shielded IV Catheter
Designed to reduce needlestick injuries

Features and Benefits

• Proven to Reduce Needlestick Injuries
• Push-Button Shielding Technology
• Finger Grip & Safety Barrel
• Maximized Indwelling Time
• Catheter Tip
• Breadth of Line
• References
  

Proven to Reduce Needlestick Injuries

Results of an Autoguard Effectiveness Study conducted by Mt. Sinai Medical Center in New York, NY, a 1,000-bed teaching hospital, clinically proved the BD Insyte Autoguard shielded IV catheter to reduce needlestick injuries by 95%. The BD Autoguard technology is the only safety-engineered catheter proven to demonstrate effective needlestick reduction.

Push-button Shielding Technology

Features:

The unique, patented activation mechanism of the BD Insyte Autoguard shielded IV catheter is a mechanical design in which the button holds the needle assembly in the forward position until the user activates the device. Pressing the button releases the spring and allows the needle and flash chamber to retract quickly into the safety barrel.

Benefits:

• Clinician maintains control of the process by allowing the user to determine when to activate the safety mechanism.
• Activation of the needle shielding mechanism can be confirmed by sight and tactile snap.
• Offers a high degree of safety in two areas: 1) needlestick injury and 2) blood exposure.

Top of page

Finger Grip & Safety Barrel

Features:

The finger grip and safety barrel are made of optically clear, polycarbonate resin. This allows for easy visualization of the flashback chamber and the shielding mechanism.

Benefits:

• Clear finger grip area allows for easy blood flashback visualization. Clear safety barrel allows for easy visualization that needle shielding has occurred.
• Once the safety mechanism is activated, the needle is completely enclosed in safety barrel.

Top of page

Maximized Indwelling Time

Features:

BD Insyte Autoguard shielded IV catheters are made of BD Vialon biomaterial, clinically proven to be easier to insert, while demonstrating superior indwelling characteristics to enhance the outcome of IV therapy.

Benefits:

• Clinically proven to offer indwelling superiority and to reduce catheter related complications. Smooth surface dramatically reduces catheter drag upon insertion. Softening ability reduces irritation to the inner lining of the vein.
• Superior flexibility will recover over 98% of flow rate after kinking.

Top of page

Catheter Tip

Features:

The patented low-profile symmetrical tip allows a minimum of resistance as the tissue transitions from the needle bevel onto the catheter.

Benefits:

• The patented catheter tip may result in an ultra-smooth penetration, greater first start efficiency, reduced catheter peelback, and less pain and trauma to the patient.

Top of page

Breadth of Line

Features:

Available in 14 to 24 gauge sizes, 0.56" to 1.88" catheter length and either straight or winged versions.

Benefits:

• Provides the widest selection of lengths and gauge sized available in a safety-engineered IV catheter product line.

Top of page

References

• Data on file at BD
• Pettit, J., Hughes, K., "Neonatal Intravenous Therapy Practices" Journal of Vascular Access Devices, Spring, 1999, pages 7-16.
• Stanley M., Meister E., Fuschuber K., "Infiltration During Intravenous Therapy in Neonates: Comparison of Teflon® and Vialon™ Catheters." Southern Medical Journal, September 1992, Vol. 85, No. 9, pages 883-886.
• Ahrens, T., Wiersema, L., Weilitz, PB, "Differences in Pain Perception Associated with Intravenous Catheter Insertion", Journal of Intravenous Nursing, Vol. 14 No. 2, March/April 1991, pages 85-89.
• Gaukroger PB, Roberts JG, Manners TA. "Infusion thrombophlebitis: a prospective comparison of 645 Vialon™ and Teflon® cannulae in anaesthetic and postoperative use." Anaesth lntens Care 1988; 16:265-271
• Maki DG, Ringer M. "Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial." Ann Intern Med 1991; 114:845-854
• McKee JM, Shell JA, Warren TA, Campbell VP. "Complications of intravenous therapy: a randomized prospective study--Vialon™ vs. Teflon®." Journal of Intravenous Nursing 1989; 12(5): 288-295.